Thursday, June 16th, 2016 - WiseGuyReports

Browse the complete report at Bipolar Disorder - Canada Drug Forecast and Market Analysis to 2024

Summary

Bipolar disorder is a mental disorder characterized by periods of mania and depression. The frequency, severity, and pattern of these episodes can vary considerably over time and between individuals, making bipolar disorder one of the most challenging psychiatric disorders to manage. The bipolar disorder market is widely genericized, with additional key brands expected to face patent or data exclusivity expiries during the forecast period. The bipolar disorder market size is anticipated to contract significantly between 2014 and 2024, driven largely by the generic erosion of Otsuka’s Abilify, the highest selling bipolar disorder product in 2014. The uptake of novel atypical antipsychotic products will be a principal driver of growth over the forecast period, as these products offer clinical advantages that will drive strong uptake. However, sales of these agents will be limited by the continued utilization of established generic products. There are currently only two products in Phase III development, which indicates that bipolar disorder will remain a field of high unmet need during the forecast period.

Estimates the value of the Canadian bipolar disorder market to have been approximately $167.8m in 2014. Canada’s market size is limited by the country’s low population. Drug sales in this country are expected to stay largely constant over the forecast period, as represented by the flat CAGR. Sales are then expected to decline between 2017 and 2023 due to the generic erosion of various brands including Otsuka’s Abilify, Pfizer’s Zeldox, Allergan’s Saphris, and Janssen’s Risperdal Consta.

Request a sample of this report at https://www.wiseguyreports.com/sample-request/bipolar-disorder-canada-drug-forecast-and-market-analysis-to-2024 .

*This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase.

Scope

- Overview of Bipolar Disorder including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. 
- Detailed information on the key drugs in Canada including product description, safety and efficacy profiles as well as a SWOT analysis. 
- Sales forecast for the top drugs in Canada from 2014-2024. 
- Analysis of the impact of key events as well the drivers and restraints affecting Canada Bipolar Disorder market.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return 
- Stay ahead of the competition by understanding the changing competitive landscape for Bipolar Disorder. 
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential 
- Make more informed business decisions from insightful and in-depth analysis of drug performance 
- Obtain sales forecast for drugs from 2014-2024 in Canada.

Check discount of this report at https://www.wiseguyreports.com/check-discount/bipolar-disorder-canada-drug-forecast-and-market-analysis-to-2024  .

15% Discount available on Single User

Buy 2 Get 3rd Free (Available for Multi brand purchase)

25% Discount on Global Site License

 

Browse related report:

Bipolar Disorder - Japan Drug Forecast and Market Analysis to 2024 @ Bipolar disorder is a mental disorder characterized by periods of mania and depression. The frequency, severity, and pattern of these episodes can vary considerably over time and between individuals, making bipolar disorder one of the most challenging psychiatric disorders to manage. The bipolar disorder market is widely genericized, with additional key brands expected to face patent or data exclusivity expiries during the forecast period. The bipolar disorder market size is anticipated to contract significantly between 2014 and 2024, driven largely by the generic erosion of Otsuka’s Abilify, the highest selling bipolar disorder product in 2014. The uptake of novel atypical antipsychotic products will be a principal driver of growth over the forecast period, as these products offer clinical advantages that will drive strong uptake. However, sales of these agents will be limited by the continued utilization of established generic products. There are currently only two products in Phase III development, which indicates that bipolar disorder will remain a field of high unmet need during the forecast period.

Bipolar Disorder - Current and Future Players @ “Bipolar Disorder - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Bipolar Disorder Market. The report identifies and analyses the key companies shaping and driving the global Bipolar Disorder market. The report provides insight into the competitive Bipolar Disorder landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by team of industry experts.

 

 

Contact Us:

Norah Trent

[email protected]

+1 646 845 9349 / +44 208 133 9349

www.wiseguyreports.com 

File Library

Contact Profile

WiseGuyReports


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.


Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349
W: www.wiseguyreports.com/

Keywords

Canada Bipolar Disorder Industry 2016, Bipolar Disorder Industry 2024, Canada Bipolar Disorder Market, , Canada Bipolar Disorder market forecast 2024, wise guy reports, market research reports

Categories

Newsrooms

Sharing

More Formats